SPDR S&P Pharmaceuticals ETF Rating $68.23 +0.17 (+0.25%) As of 08/3/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.71Holdings in XPH have an aggregate rating of Moderate Buy based on 304 analyst ratings issued in the past year covering 25 companies (50.6% of the portfolio).XPH Aggregate Price Target$68.23High Prediction$68.23Average Prediction$68.23Low Prediction$68.23Holdings in XPH have an aggregate price target of $68.23 and a range of $68.23 to $68.23 covering 25 companies (50.6% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.69%CRNXCrinetics Pharmaceuticals$83.76+0.3%2.1323 of 5 stars2.24$81.00 -3.3%17Earnings Report2.88%ATAIAtai Beckley$7.182.7202 of 5 stars2.27$11.06 54.0%152.85%MBXMBX Biosciences$64.41-2.3%2.1407 of 5 stars2.75$71.13 10.4%12Positive News2.84%DFTXDefinium Therapeutics$41.79-4.0%3.6412 of 5 stars3.00$54.85 31.2%182.17%ALMSAlumis$26.12-7.5%4.3571 of 5 stars2.83$40.30 54.3%12Positive NewsAnalyst Forecast2.17%NUVBNuvation Bio$6.17-2.6%3.6634 of 5 stars2.64$12.88 108.8%11Upcoming EarningsGap Up2.16%ELVNEnliven Therapeutics$58.04+5.9%2.8045 of 5 stars2.86$70.50 21.5%7Positive NewsHigh Trading Volume2.02%LQDALiquidia$83.85-0.3%3.2945 of 5 stars2.82$86.18 2.8%111.99%AMLXAmylyx Pharmaceuticals$20.17-0.7%4.0132 of 5 stars2.90$25.38 25.8%10News CoverageUpcoming EarningsAnalyst Forecast1.96%TRVITrevi Therapeutics$17.90-1.9%3.2058 of 5 stars3.00$24.91 39.2%12Upcoming Earnings1.86%LGNDLigand Pharmaceuticals$292.04+1.6%4.4896 of 5 stars2.88$326.00 11.6%8Positive NewsUpcoming EarningsAnalyst Forecast1.85%NKTRNektar Therapeutics$70.59-0.1%2.9435 of 5 stars2.75$150.00 112.5%12Positive News1.81%HROWHarrow$39.09+0.8%3.9309 of 5 stars2.64$69.43 77.6%11Upcoming Earnings1.79%MANEVeradermics$100.97-3.8%2.3177 of 5 stars2.67$153.00 51.5%9Analyst UpgradeLockup ExpirationHigh Trading Volume1.76%CORTCorcept Therapeutics$112.80-1.5%3.1373 of 5 stars2.63$119.17 5.6%8Earnings ReportAnalyst UpgradeInsider TradeAnalyst Revision1.76%EWTXEdgewise Therapeutics$38.38-0.1%3.5187 of 5 stars2.82$48.75 27.0%11Positive NewsUpcoming Earnings1.75%AMRXAmneal Pharmaceuticals$18.85+2.9%2.9074 of 5 stars2.88$17.67 -6.3%8Positive NewsAnalyst Forecast1.75%MAZEMaze Therapeutics$27.33+1.5%2.3054 of 5 stars3.00$66.00 141.5%11Positive News1.68%ELANElanco Animal Health$25.68-2.6%3.1866 of 5 stars2.77$28.73 11.9%13Positive NewsUpcoming Earnings1.65%BMYBristol Myers Squibb$65.45+0.2%3.9521 of 5 stars2.36$63.59 -2.8%22Trending NewsEarnings ReportAnalyst ForecastHigh Trading Volume1.65%JAZZJazz Pharmaceuticals$251.58-0.5%2.5741 of 5 stars2.90$259.06 3.0%20Earnings ReportHigh Trading Volume1.65%PCRXPacira BioSciences$26.92+1.9%2.1106 of 5 stars2.29$29.40 9.2%7News CoverageHigh Trading Volume1.63%RPRXRoyalty Pharma$57.17-2.2%4.1355 of 5 stars3.00$56.57 -1.0%7Positive NewsUpcoming Earnings1.63%VTRSViatris$17.63+0.4%2.2347 of 5 stars2.57$17.50 -0.7%7Upcoming Earnings1.62%JNJJohnson & Johnson$254.54-0.7%4.6273 of 5 stars2.80$267.48 5.1%25Trending NewsAnalyst Downgrade This page (NYSEARCA:XPH) was last updated on 8/4/2026 by MarketBeat.com Staff. From Our PartnersWhere to Put $100 Before Trump's New Tech Law Rolls OutThe Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredThis AI fund sends investors payouts every ThursdayCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored1 Stock to Own by July 31stA scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...Chaikin Analytics | SponsoredHe bet half his $9 billion on ONE stockOne of the most successful fund managers of the past 50 years put more than $4.5 billion - over half his fund ...Stansberry Research | SponsoredApple just sent a powerful signal to investorsApple just crossed a $5 trillion market value as shares climbed 25% this year, fueled by new product launches ...Mode Mobile | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
